by Chris Kamel | Mar 2, 2011
They’re promising, but not perfect. Induced pluripotent stem cells are perhaps one of the most studied areas of stem cell research today, as researchers work to improve their method of production, but new findings out of Canada and Finland suggests that the...
by Chris Kamel | Feb 28, 2011
We’ve talked often about induced pluripotent stem cells (iPS cells) on this blog — the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages — mostly in the context of discoveries in mice...
by Michelle Ly | Feb 22, 2011
As we get further into 2011, embryonic stem (ES) cells continue to be a hot topic. The ability of ES cells to differentiate into virtually any other type of cell makes them a prime avenue for research in biomedical applications. They have also been a source of great...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
by David Kent | Feb 11, 2011
One of the most striking observations I have made since I began my stem cell training involves the hugely positive effects of substantial resources on the field of stem cell biology. Building on the momentum of two stunning advances in developmental biology in the...
by Ubaka Ogbogu | Feb 8, 2011
A few weeks ago I blogged about the recent Supreme Court of Canada decision on the constitutional validity of several sections of the Assisted Human Reproduction Act, Canada’s assisted reproduction and embryo research legislation. I am currently preparing a paper for...
by Paul Krzyzanowski | Feb 1, 2011
Last month, The Economist published a very dismal article about PhD holder’s employment prospects entitled “The Disposable Academic”. Ouch. Nevertheless, the article made its rounds through the Internet and I received the link at least six times. It was very critical...
by Stem Cell Network | Jan 27, 2011
Earlier this week, many of the world’s leading scientists engaged in developing stem cell-based treatments for Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) met for the first time as a group to share their work. Held in New York, the meeting was...
by David Grant | Jan 26, 2011
How do newspaper articles portray stem cell tourism? A research team at the University of Alberta recently asked this question, and their results were published last month in the journal Nature. Their conclusions were both surprising, and hopeful. The team, led by...
by Chris Kamel | Jan 24, 2011
Although tumours are typically thought of as a single entity, the cells that make up a tumour are genetically diverse. The traditional view of cancer progression — in which a tumour arises from a single cell after accumulated mutations — suggests that...
Comments